NMS·Healthcare·$2.8B·#121 / 520 in Healthcare
CLOV Clover Health Investments, Corp
62SOLID
CATEGORY BREAKDOWN
GROWTH65
QUALITY44
STABILITY65
VALUATION99
GOVERNANCE57
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+40.3%
65
> 50% strong
Gross Margin
Revenue retained after direct costs
18.5%
25
> 50% strong
Cash Runway
Months of cash at current burn rate
14 months
48
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
1.5%
99
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.3x
99
< 3x strong
Rule of 40
Growth rate plus operating margin
36
74
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
4.4%
35
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-20.0%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE CLOV WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when CLOV's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.